ArticleJournal of the American Society of Nephrology : JASN2018
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Xiaoxin X Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
134 papers cite itlatest 60 shown
this paperpooled itcites it